… IN 1975, a project was initiated by the Programme on Clinical Oncology of the UICC to
formulate a system forthe evaluation of response to treatment of advanced cancer. It was …

… Our understanding of the biology of cancer and the application of this knowledge to cancer
… and toxic effects that therapies produce. These adverse effects of therapy cause substantial …

… There are currently no established benchmarks to guide clinicians with regard to timely
access and assessment of patients who experience cancer-related cardiotoxicity. For …

… the risk of getting cancer can be identified, cancer risk assessment has become increasingly
vital … Risk assessment screening of apparently healthy people is now used in many cancer …

… matched to an iCat recommendation, this study was not designed primarily to assess the
impact of receipt of matched targeted therapy on outcome. Additional limitations of this study …

… Though DCE-MRI is becoming one of the imaging modalities of choice for assessment of
cancer therapy response in early phase clinical trials, systematic comparison and validation of …

… access to novel therapies. These advances require ongoing research to assess and manage
the … cardiovascular toxicities for a range of cancer chemotherapeutics and to review general …

… Cancer is a leading cause of death worldwide. Currently available therapies are inadequate
… great promise to improve therapeutic strategies against cancer. Nanomedicine products …

… -53%), therapy may be stated with at a cost of increased vigilance. Thereafter, assessment of
… 3-month intervals during therapy, and this should be followed by LVEF assessment every 6 …

… method for the assessment of quality of life in patients receiving cancer therapy, and …
Assessment of quality of life of patients receiving cancer treatment is an essential part of the practice …